Drugs Made In America Acquisition II Corp. Ordinary Shares Net Asset Quality Index
Drugs Made In America Acquisition II Corp. Ordinary Shares net asset quality index. Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Net Asset Quality Index of 96.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $514.10 Million minus total liabilities of $18.14 Million yields net assets of $495.96 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Drugs Made In America Acquisition II Cor (DMII) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
Net asset quality index of Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025. This chart shows how Drugs Made In America Acquisition II Corp. Ordinary Shares's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 96.5%, representing net assets of $495.96 Million against total assets of $514.10 Million USD. Check DMII tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Drugs Made In America Acquisition II Corp. Ordinary Shares Net Asset Quality Index by Year (2024–2025)
Drugs Made In America Acquisition II Corp. Ordinary Shares net asset quality index by year from 2024 to 2025. The table below presents the year-by-year Net Asset Quality Index for Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see DMII stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $487.16 Million | $504.96 Million | $17.80 Million | ▲ +181.0 pp |
| 2024 | -84.5% | $-116.72K | $138.06K | $254.78K | — |